Want to see JP:9158 full AI Analyst Report?
Top Page
CUC Inc.
(9158)
Select Model
Select Model
Rating:53Neutral
Price Target:
¥746.00
▼(-12.03% Downside)
Action:Reiterated
Date:08/09/26
The score is primarily held back by financial quality concerns—persistently negative free cash flow, weak cash conversion, and rising leverage—despite improving revenue growth. Technicals further weigh on the score due to a clear downtrend and weak momentum. Valuation provides partial support with a low P/E, but it does not fully offset the cash flow and balance sheet risks.
Positive Factors
Revenue Growth
The renewed top-line acceleration indicates improving demand and business momentum. If sustained, stronger revenue growth can support operating scale, broaden the company’s care-facility platform, and help offset some margin and financing pressures.
Negative Factors
Negative Free Cash Flow
Persistent negative free cash flow indicates that reinvestment or working-capital needs are absorbing more cash than the business generates. Continued deficits could require external funding, constrain strategic flexibility, and increase dependence on debt.
Read all positive and negative factors
Positive Factors
Negative Factors
Revenue Growth
The renewed top-line acceleration indicates improving demand and business momentum. If sustained, stronger revenue growth can support operating scale, broaden the company’s care-facility platform, and help offset some margin and financing pressures.
Read all positive factors
CUC Inc. (9158) vs. iShares MSCI Japan ETF (EWJ)
Market Cap
¥22.22B
Dividend YieldN/A
Average Volume (3M)71.70K
Price to Earnings (P/E)9.4
Beta (1Y)1.03
Revenue Growth12.29%
EPS Growth-0.34%
CountryJP
Employees5,740
SectorHealthcare
Sector Strength45
IndustryMedical - Care Facilities
Share Statistics
EPS (TTM)80.67
Shares Outstanding29,990,400
10 Day Avg. Volume30,420
30 Day Avg. Volume71,703
Financial Highlights & Ratios
PEG Ratio-1.01
Price to Book (P/B)0.77
Price to Sales (P/S)0.47
P/FCF Ratio-28.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)32.75
Revenue Forecast (FY)¥62.70B
CUC Inc. Business Overview & Revenue Model
Company Description
CUC Inc. delivers a diverse range of healthcare provisions across Japan, throughout Asia, and globally. Their services cover critical areas like inpatient hospital care, specialized dialysis treatments, visiting nurse programs, and home hospice su...
CUC Inc. Financial Statement Overview
Summary
Income Statement
67
Positive
Balance Sheet
56
Neutral
Cash Flow
38
Negative
| Breakdown | TTM | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 55.52B | 54.35B | 47.04B | 33.02B | 35.21B | 35.31B |
| Gross Profit | 25.73B | 25.41B | 19.90B | 14.12B | 12.55B | 13.18B |
| EBITDA | 8.00B | 8.51B | 8.08B | 5.52B | 4.93B | 6.53B |
| Net Income | 2.36B | 2.85B | 3.13B | 2.60B | 2.42B | 2.71B |
Balance Sheet | ||||||
| Total Assets | 101.14B | 98.05B | 85.17B | 62.84B | 39.75B | 34.53B |
| Cash, Cash Equivalents and Short-Term Investments | 18.33B | 15.84B | 7.53B | 8.26B | 4.12B | 4.36B |
| Total Debt | 56.69B | 52.53B | 43.54B | 26.72B | 21.45B | 14.90B |
| Total Liabilities | 67.32B | 64.16B | 54.88B | 34.83B | 27.83B | 24.85B |
| Stockholders Equity | 33.43B | 33.25B | 29.68B | 27.32B | 11.70B | 9.46B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | -912.00M | -3.04B | -703.00M | -3.10B | 5.79B |
| Operating Cash Flow | 0.00 | 5.71B | 2.50B | 4.16B | 2.36B | 6.62B |
| Investing Cash Flow | 0.00 | -3.38B | 4.45B | -14.75B | -6.68B | -1.47B |
| Financing Cash Flow | 0.00 | 5.92B | -7.60B | 14.37B | 3.97B | -4.43B |
CUC Inc. Technical Analysis
Neutral
848.00
Price Trends
770.00
Negative
807.11
Negative
858.00
Negative
Market Momentum
-5.75
Negative
53.54
Neutral
76.79
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For JP:9158, the sentiment is Neutral. The current price of 848 is above the 20-day moving average (MA) of 737.80, above the 50-day MA of 770.00, and below the 200-day MA of 858.00, indicating a neutral trend. The MACD of -5.75 indicates Negative momentum. The RSI at 53.54 is Neutral, neither overbought nor oversold. The STOCH value of 76.79 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Neutral sentiment for JP:9158.
CUC Inc. Peers Comparison
UnderperformOutperform
Sector (51)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
74 Outperform | ¥46.08B | 11.41 | ― | 3.04% | 5.16% | 37.79% | |
64 Neutral | ¥2.35B | 4.86 | ― | 3.83% | 2.01% | 2.55% | |
58 Neutral | ¥5.64B | 11.68 | ― | 0.40% | 13.29% | 17.57% | |
53 Neutral | ¥22.22B | 9.40 | ― | ― | 12.29% | -0.34% | |
51 Neutral | $7.86B | -0.30 | -43.30% | 2.27% | 22.53% | -2.21% | |
49 Neutral | ¥5.53B | 52.76 | ― | 4.14% | 4.85% | -85.27% | |
46 Neutral | ¥4.05B | 12.22 | ― | 5.24% | 14.91% | -39.00% |
* Healthcare Sector Average
JP:9158
CUC Inc.
758.00
-472.00
-38.37%
JP:2373
Care Twentyone Corporation
411.00
4.79
1.18%
JP:2435
Cedar. Co.,Ltd
209.00
-11.03
-5.01%
JP:6062
Charm Care Corporation
1,413.00
398.91
39.34%
JP:7061
Japan Hospice Holdings Inc.
477.00
-812.75
-63.02%
JP:7091
Living Platform Ltd.
1,257.00
314.97
33.44%
CUC Inc. Corporate Events
CUC Inc. Posts Revenue Growth but Swings to Quarterly Loss
Jul 30, 2026
CUC Inc., listed on the Tokyo Stock Exchange, operates in the services sector with a focus reflected in recurring revenue-generating operations across Japan. The company reports under IFRS and targets steady top-line growth while managing profitab...
CUC Details Governance Safeguards Under M3’s Majority Control
Jun 25, 2026
CUC Inc. disclosed details of its relationship with controlling shareholder M3, Inc., which holds 63.46% of CUC’s voting rights and positions the company within M3’s Site Solution segment serving healthcare professionals worldwide. The...
CUC Inc. Corrects Select Figures in FY2026 Consolidated Results
Jun 4, 2026
CUC Inc., a Tokyo Stock Exchange Growth-listed company, has issued a correction to its previously announced consolidated financial results for the fiscal year ended March 31, 2026 under IFRS. While the firm does not detail its operating sector in ...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.